Cart (0 Items)
Your cart is currently empty.
View ProductsTNFa / TNF-alpha, N-His, recombinant protein
| size | 100ug |
|---|---|
| Brand | ProteoGenix |
| Product type | Recombinant Proteins |
| Host Species | Mammalian cells |
| Applications | Elisa, WB |
| Product name | TNFa / TNF-alpha, N-His, recombinant protein |
|---|---|
| Origin species | Homo sapiens (Human) |
| Expression system | Eukaryotic expression |
| Molecular weight | 25.65 kDa |
| Protein delivered with Tag? | N-terminal His Tag |
| Purity estimated | >90% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Delivery condition | Dry Ice |
| Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
| Brand | ProteoGenix |
| Host species | Mammalian cells |
| Applications | ELISA,WB |
| Fragment Type | Val77-Leu233 |
| Protein Accession | P01375 |
| Aliases /Synonyms | cachexin, cachectin |
| Reference | PX-P5961 |
| Note | For research use only |
Description of TNFa / TNF-alpha, N-His, recombinant protein
General information on TNFa / TNF-alpha, N-His, recombinant protein
TNF-Alpha: Cytokine Protein
TNF-alpha, also known as tumor necrosis factor-alpha, is a cytokine protein produced mainly by macrophages and other white blood cells. It is involved in the regulation of immune responses, inflammation, and cell death. TNF-alpha binds to two receptors, TNFR1 and TNFR2, which are present on the surface of many cell types. Binding to TNFR1 activates the pro-inflammatory signals, while binding to TNFR2 leads to cell death.
TNF-Alpha: Antibody-Drug Target
TNF-alpha is a target for antibody-drugs used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease. These drugs are monoclonal antibodies that bind to TNF-alpha and inhibit its activity, thus reducing inflammation and preventing tissue damage. Infliximab and adalimumab are two of the most commonly used TNF-alpha inhibitors.
TNF-Alpha: Application
TNF-alpha has also been studied for its potential therapeutic applications. It has been used in cancer therapy to induce apoptosis in tumor cells, and it has been studied as a potential treatment for HIV infection.
SDS-PAGE for TNFa / TNF-alpha, N-His, recombinant protein
TNFa / TNF-alpha, N-His, recombinant protein on SDS-PAGE under reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is superior than 90 %.
Related products
Biosimilar
Afelimomab Biosimilar – Anti-TNFSF2, TNF-alpha, TNFA mAb – Research Grade
PX-TA1088 400€
Biosimilar
Golimumab Biosimilar – Anti-TNFA, TNF alpha mAb – Research Grade
PX-TA1129 300€
Biosimilar
CDP571 Biosimilar – Anti-TNFSF2, TNF alpha, TNFA mAb – Research Grade
PX-TA1154 400€
Biosimilar
Nerelimomab Biosimilar – Anti-TNFSF2, TNF-alpha, TNFA mAb – Research Grade
PX-TA1219 400€
Biosimilar
Ozoralizumab Biosimilar – Anti-ALB, TNFSF2, TNF-alpha, TNFA mAb – Research Grade
PX-TA1272 400€
Biosimilar
Placulumab Biosimilar – Anti-TNFSF2, TNF-alpha, TNFA mAb – Research Grade
PX-TA1302 400€
Biosimilar
Remtolumab Biosimilar – Anti-IL17A, TNFSF2, TNF-alpha, TNFA mAb – Research Grade
PX-TA1362 400€
Biosimilar
Licaminlimab Biosimilar – Anti-TNFA mAb – Research Grade
PX-TA1679 400€
Receptor
CD120a Recombinant Protein
PX-P4100 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.